Compile Data Set for Download or QSAR
Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 50001039
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268236(CHEMBL4101718)
Affinity DataIC50: 2.10nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268214(CHEMBL4070852)
Affinity DataIC50: 2.60nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268237(CHEMBL4060964)
Affinity DataIC50: 3.90nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268236(CHEMBL4101718)
Affinity DataIC50: 3.90nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268214(CHEMBL4070852)
Affinity DataIC50: 4.30nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268213(CHEMBL4092798)
Affinity DataIC50: 4.60nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268235(CHEMBL4074342)
Affinity DataIC50: 5.10nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268215(CHEMBL4100114)
Affinity DataIC50: 5.70nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268216(CHEMBL4060897)
Affinity DataIC50: 6.10nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268217(CHEMBL4064789)
Affinity DataIC50: 6.10nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268212(CHEMBL4077605)
Affinity DataIC50: 6.20nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268193(CHEMBL4059929)
Affinity DataIC50: 6.70nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268194(CHEMBL4100523)
Affinity DataIC50: 7.30nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268217(CHEMBL4064789)
Affinity DataIC50: 7.30nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268237(CHEMBL4060964)
Affinity DataIC50: 7.60nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268215(CHEMBL4100114)
Affinity DataIC50: 7.80nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268222(CHEMBL4063587)
Affinity DataIC50: 9.60nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268219(CHEMBL4073378)
Affinity DataIC50: 14nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268220(CHEMBL4094029)
Affinity DataIC50: 14nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268220(CHEMBL4094029)
Affinity DataIC50: 16nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268218(CHEMBL4086265)
Affinity DataIC50: 18nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268219(CHEMBL4073378)
Affinity DataIC50: 19nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268216(CHEMBL4060897)
Affinity DataIC50: 23nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268194(CHEMBL4100523)
Affinity DataIC50: 25nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268212(CHEMBL4077605)
Affinity DataIC50: 25nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268235(CHEMBL4074342)
Affinity DataIC50: 29nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268193(CHEMBL4059929)
Affinity DataIC50: 37nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268222(CHEMBL4063587)
Affinity DataIC50: 57nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268221(CHEMBL4083763)
Affinity DataIC50: 58nMAssay Description:Antagonist activity at human SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268218(CHEMBL4086265)
Affinity DataIC50: 62nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268221(CHEMBL4083763)
Affinity DataIC50: 78nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed
TargetSomatostatin receptor type 5(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50268213(CHEMBL4092798)
Affinity DataIC50: 85nMAssay Description:Antagonist activity at mouse SSTR5 expressed in CHO cells assessed as inhibition of SST14-induced forskolin-stimulated intracellular cAMP level incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/3/2020
Entry Details Article
PubMed